NCT05125575View on ClinicalTrials.gov

Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 11, 2019

Primary Completion Date

January 19, 2019

Study Completion Date

January 19, 2019

Conditions

Pharmacokinetics

Interventions

DRUG

Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)

One tablet of the Test (T) product was administered orally with 240 mL of water.

DRUG

Glucophage® XR 1000 mg Prolonged Release Tablets

One tablet of the Reference (R) product was administered orally with 240 mL of water.

Trial Locations (1)

10200

QUINTA-ANALYTICA s.r.o., Prague

All Listed Sponsors

lead

"Joint Stock Company Farmak"

INDUSTRY

NCT05125575 - Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter